Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
International Journal of Cancer|January 11, 2021
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational studySandrine Monestier, Stéphane Dalle, Laurent Mortier, et al.The Journal of Investigative Dermatology|August 28, 2017
STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer NetworkJulie Delyon, Sylvie Chevret, Thomas Jouary, et al.European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Prognostic classification of skin adnexal carcinomas: Results from a prospective study of 980 patients in the French CARADERM networkRobin Zagala, Stephane Dalle, Brigitte Balme, et al.Current Oncology (Toronto, Ont.)|December 22, 2022
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in FranceMarguerite Kandel, Aurélie Bardet, Stéphane Dalle, et al.Cancer|October 23, 2019
Quality-of-life assessment in French patients with metastatic melanoma in real lifeMarguerite Kandel, Stéphane Dalle, Aurélie Bardet, et al.Journal of Oncology|January 12, 2019
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal MelanomaClaire Mignard, Aurélie Deschamps Huvier, André Gillibert, et al.European Journal of Cancer (Oxford, England : 1990)|March 10, 2026
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCACaroline Robert, Emilie Gérard, Emilie Lanoy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell CarcinomasEve Maubec, Marouane Boubaya, Peter Petrow, et al.Archives of Dermatology|July 18, 2012
Prognostic factors of paraneoplastic pemphigusSandy Leger, Damien Picard, Saskia Ingen-Housz-Oro, et al.Journal of the American Academy of Dermatology|March 3, 2019
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohortSarah Faiz, Jonathan Giovannelli, Céline Podevin, et al.Pageof 5